LUXEMBOURG, Aug. 23, 2013 /PRNewswire/ -- ConvaTec today announced that it will report its 2013 second quarter earnings on Wednesday, August 28, 2013. Ken Berger, CEO, and John Cannon, acting CFO, will host an analyst and investor call at 9:00 AM ET live via telephone.
To participate in the conference call within the U.S. and Canada, dial (877) 366-0267.
To participate in the conference call outside the U.S. and Canada, dial (760) 666-3086.
The conference ID is 35722179.
Participants should dial in 10 minutes prior to the start of the call. The Company's 2013 Second Quarter Report will be available on the Company's website prior to the call under the Investor Community at www.convateccorporate.com.
For more information, please contact firstname.lastname@example.org.
ConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key focus areas Ostomy Care, Wound Therapeutics, Continence and Critical Care, and Infusion Devices ConvaTec products support healthcare professionals from the hospital to the community health setting. For more information, please visit www.convatec.com.